Monopar Therapeutics Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Monopar Therapeutics quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2021 to Q3 2024.
  • Monopar Therapeutics Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $0 -$25.1K -100% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $0 -$37.3K -100% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $0 -$49.4K -100% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $12.6K -$48.6K -79.3% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $25.1K -$47.8K -65.6% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $37.3K -$47K -55.8% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $49.4K -$4.32K -8.04% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $61.2K +$61.2K Dec 31, 2022 10-K 2024-03-28
Q3 2022 $72.9K +$72.9K Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $84.4K Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $53.7K Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $0 Sep 30, 2021 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.